INBX 1H TRADE IDEA got into the box after the false break out I see it will break make an attempt to exit the box balance area once more 2:1 trade idea
−5.03USD
−241.36 MUSD
1.80 MUSD
35.60 M
About Inhibrx, Inc.
Sector
Industry
CEO
Mark P. Lappe
Website
Headquarters
La Jolla
Employees (FY)
172
Founded
2010
ISIN
US45720L1070
FIGI
BBG00P80N9T9
Inhibrx, Inc., is a clinical stage biotechnology company, focuses on developing pipeline of novel biologic therapeutic candidates. The firm’s pipeline is focused on oncology, orphan diseases and infectious diseases. It utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The company was founded by Mark Paul Lappe, Quinn Deveraux and Brendan P. Eckelman in April 2010 and is headquartered La Jolla, CA.
Short/Long $INBX Trade IdeaAs we can see $INBX "ping pong" between is "R"=resistance and "S" =support levels
Im the case he break is support we got a high chances he will retrace to close his gap or a t least check the gap horizontal support line there is no structure in the way down but recent candela from the prior month
$INBX is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Inhibrx is advancing a pipeline of candidates for the treatment of various rare cancers and AATD.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of INBX is 34.67 USD — it has increased by 0.17% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Inhibrx, Inc. stocks are traded under the ticker INBX.
Inhibrx, Inc. is going to release the next earnings report on May 6, 2024. Keep track of upcoming events with our Earnings Calendar.
INBX stock is 0.41% volatile and has beta coefficient of 2.63. Check out the list of the most volatile stocks — is Inhibrx, Inc. there?
One year price forecast for Inhibrx, Inc. has a max estimate of 36.00 USD and a min estimate of 35.00 USD.
INBX earnings for the last quarter are −1.10 USD whereas the estimation was −1.01 USD which accounts for −8.91% surprise. Estimated earnings for the next quarter are −1.04 USD. See more details about Inhibrx, Inc. earnings.
Inhibrx, Inc. revenue for the last quarter amounts to 119.00 K USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach 50.00 K USD.
Yes, you can track Inhibrx, Inc. financials in yearly and quarterly reports right on TradingView.
INBX stock has fallen by 2.12% compared to the previous week, the month change is a 0.72% fall, over the last year Inhibrx, Inc. has showed a 72.57% increase.
INBX net income for the last quarter is −93.60 M USD, while the quarter before that showed −51.79 M USD of net income which accounts for −80.74% change. Track more Inhibrx, Inc. financial stats to get the full picture.
Today Inhibrx, Inc. has the market capitalization of 1.64 B, it has decreased by 0.43% over the last week.
No, INBX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, INBX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Inhibrx, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 172.00 employees. See our rating of the largest employees — is Inhibrx, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Inhibrx, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Inhibrx, Inc. stock shows the buy signal. See more of Inhibrx, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Inhibrx, Inc. future price: according to them, INBX price has a max estimate of 36.00 USD and a min estimate of 35.00 USD. Read a more detailed Inhibrx, Inc. forecast: see what analysts think of Inhibrx, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Inhibrx, Inc. EBITDA is −217.17 M USD, and current EBITDA margin is −12.11 K%. See more stats in Inhibrx, Inc. financial statements.